Use of Impella 5.5 in patients with cardiogenic shock as a bridge to decision, recovery, or destination therapy
Anju Bhardwaj, Ismael Salas de Armas, Dina Al Rameni, Manish Kumar Patel, Mehmet H. Akay, Biswajit Kar, Igor D. Gregorič
Abstract
The overall morbidity and mortality rates of cardiogenic shock are high. The Impella 5.5 is a temporary mechanical circulatory support device that treats cardiogenic shock by supporting a failing ventricle. It is used as a bridge to advanced therapy, decision, or recovery. We report our initial experience with this device.
Topics & Concepts
ImpellaCardiogenic shockMedicineCirculatory systemVentricleBridge (graph theory)Shock (circulatory)CardiologyDestination therapyInternal medicineIntensive care medicineVentricular assist deviceMyocardial infarctionHeart failureMechanical Circulatory Support DevicesCardiac Structural Anomalies and RepairCardiac Arrest and Resuscitation